The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Behrenbruch Christian since 2026.
This trader's CIK number is 2037713.
At the time of last reporting, Behrenbruch Christian was the MD & Group CEO of Telix Pharmaceuticals Ltd. (stock ticker symbol TLX).
Also see all insider trading activities at Telix Pharmaceuticals Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | TLX | 67,935 | $996,738 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-29 | TLX | Buy | 33,435 | 14.87 | 497,178 |
| 2026-04-28 | TLX | Buy | 34,500 | 14.48 | 499,560 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Behrenbruch Christian (MD & Group CEO of Telix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.